Cosmos Health Inc.
COSM· Nasdaq· Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -13.0%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +3.3%
We record prices for the companies we cover; COSM is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 30.3M
- Revenue
- $65.3M
- Free cash flow
- -$8.5M
- Owner earnings
- -$10.8M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 12.1%
- Operating
- -25.6%
- Net
- -29.3%
- Free cash flow
- -13.0%
- Owner earnings
- -16.6%
- Stock pay
- 3.5%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -103.9%
- ROE, 5 yr avg
- -87.7%
Growth (CAGR)
- Revenue, 3 yr
- 9.0%
- Revenue, 5 yr
- 3.3%
- Revenue, 9 yr
- 28.7%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 9 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 9 yr
- –
Financial health · FY2025
- Cash and investments
- $761.8K
- Total debt
- $3.8M
- Net debt
- $3.0M
- Debt/Equity
- 0.2x
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 124.4%
Financials: ten years from the 10-Ks
Revenue
$65.3M
+28.7% a year over 9 years
FY2016FY2025
Margins
Gross12.1%Operating-25.6%Net-29.3%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow-$8.5MOwner earnings-$10.8M
FY2025
FY2016FY2025
Diluted shares
30.3M
+502.7% over 9 years, net dilution
FY2016FY2025
Net debt (below zero)
-$3.0M
$3.0M more debt than cash
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $6.8M | $30.0M | $37.1M | $39.7M | $55.4M | $56.2M | $50.3M | $53.4M | $54.4M | $65.3M |
| Revenue growth | 1165.5% | 344.3% | 23.6% | 7.0% | 39.6% | 1.5% | -10.5% | 6.0% | 2.0% | 19.9% |
| Gross margin | 8.9% | 6.5% | 6.5% | 9.2% | 14.5% | 14.8% | 11.8% | 8.1% | 7.9% | 12.1% |
| Operating margin | -3.0% | -16.2% | -3.3% | -0.6% | 4.9% | -8.1% | -14.8% | -40.9% | -28.6% | -25.6% |
| Net income | -$601.0K | -$6.2M | -$9.1M | -$3.3M | $820.8K | -$8.0M | -$13.8M | -$18.5M | -$16.2M | -$19.1M |
| Net margin | -8.9% | -20.7% | -24.4% | -8.3% | 1.5% | -14.2% | -27.5% | -34.7% | -29.7% | -29.3% |
| Diluted EPS | $2,018,525.00s | $-12.25s | $-17.00s | $-6.25s | $1.50s | $-23.74 | $-33.16 | $-2.15 | $-1.17 | $-0.63 |
| Return on invested capital? | – | – | – | – | – | – | – | – | – | – |
| Cash | ||||||||||
| Operating cash flow | -$2.1M | -$8.8M | -$1.6M | -$4.8M | -$11.5M | -$7.1M | -$14.9M | -$15.6M | -$7.7M | -$8.4M |
| Capital expenditure | $12.8K | $55.3K | $503.4K | – | $117.7K | $581.4K | $74.2K | $1.3M | $418.1K | $55.7K |
| Free cash flow | -$2.1M | -$8.8M | -$2.1M | – | -$11.6M | -$7.7M | -$14.9M | -$16.9M | -$8.1M | -$8.5M |
| Stock-based compensation | $16.6K | $338.8K | $242.0K | – | – | $5.9M | $24.4K | $577.9K | $1.7M | $2.3M |
| Owner earnings? | -$2.2M | -$9.2M | -$2.3M | – | – | -$13.6M | -$15.0M | -$17.5M | -$9.8M | -$10.8M |
| Free cash flow per share | $-0.43 | $-17.24 | $-3.87 | – | $-21.83 | $-11.69 | $-7.75 | – | $-0.42 | $-0.28 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | $200.0K | $376.9K | – | $100.5K | $0 | – |
| Diluted shares | 5.0Ms | 511,200.52s | 532,264.48s | 530,943.84s | 532,311.76s | 656,933 | 1.9M | – | 19.1M | 30.3M |
| Share count change? | 0.0% | -89.8% | 4.1% | -0.2% | 0.3% | 23.4% | 193.5% | – | – | 58.2% |
| Balance sheet | ||||||||||
| Cash and equivalents | $716.6K | $782.9K | $864.3K | $38.5K | $628.4K | $286.5K | $20.7M | $3.8M | $315.1K | $715.7K |
| Short-term investments | – | – | $2.7M | $238.9K | $222.8K | $11.5K | $14.9K | $20.1K | $21.1K | $46.2K |
| Total debt | – | $121.6K | $145.5K | $0 | $10.8M | $477.6K | $5.0M | $4.6M | $4.1M | $3.8M |
| Net debt | – | -$661.2K | -$3.4M | -$277.5K | $9.9M | $179.7K | -$15.7M | $753.0K | $3.8M | $3.0M |
| Shareholders' equity | -$1.8M | -$3.0M | -$3.3M | -$6.5M | -$4.2M | $4.4M | $39.3M | $36.0M | $24.5M | $18.4M |
Latest filings
| 2026-10-22 | 8-K | Earnings release |
| 2026-10-09 | 8-K | Earnings release |
| 2026-08-20 | 8-K | Earnings release |
| 2026-08-18 | 10-Q | Quarterly report |
| 2026-06-02 | DEF 14A | Proxy statement |
| 2026-05-22 | 8-K | Earnings release |
| 2026-05-20 | 10-Q | Quarterly report |
| 2026-04-16 | 8-K | Earnings release |
| 2026-04-15 | 10-K | Annual report |
| 2025-11-17 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
